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Deletion of the Cul1 gene in mice causes arrest in early
embryogenesis and accumulation of cyclin E
Yisong Wang*, Sonya Penfold*, Xiaojing Tang*, Naka Hattori†, Paul Riley†,
J. Wade Harper‡, James C. Cross† and Mike Tyers*
The stability of many proteins is controlled by the
ubiquitin proteolytic system, which recognizes specific
substrates through the action of E3 ubiquitin ligases [1].
The SCFs are a recently described class of ubiquitin
ligase that target a number of cell cycle regulators and
other proteins for degradation in both yeast and
mammalian cells [2–6]. Each SCF complex is composed
of the core protein subunits Skp1, Rbx1 and Cul1
(known as Cdc53 in yeast), and substrate-specific
adaptor subunits called F-box proteins [2–4]. To
understand the physiological role of SCF complexes in
mammalian cells, we generated mice carrying a deletion
in the Cul1 gene. Cul1–/– embryos arrested around
embryonic day 6.5 (E6.5) before the onset of
gastrulation. In all cells of the mutant embryos, cyclin E
protein, but not mRNA, was highly elevated. Outgrowths
of Cul1–/– blastocysts had limited proliferative capacity
in vitro and accumulated cyclin E in all cells. Within
Cul1–/– blastocyst cultures, trophoblast giant cells
continued to endocycle despite the elevated cyclin E
levels. These results suggest that cyclin E abundance is
controlled by SCF activity, possibly through SCF-
dependent degradation of cyclin E.
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Results and discussion
A targeting vector was designed to replace exon 2 of the
murine Cul1 gene (Figure 1a), and thereby delete the trans-
lation initiation codon and an essential Skp1-binding site.
Cul1+/– embryonic stem (ES) cell clones did not express any
detectable truncated Cul1 protein products, indicating that
the targeted locus is probably a null allele (Figure 1b,c).
Chimeric animals were generated from the targeted ES
cells to introduce the Cul1 mutation into the mouse
germline (Figure 1d). We have not observed any abnormal
phenotype in Cul1+/– animals at up to 15 months of age.
Analysis of progeny derived from crosses of Cul1 hetero-
zygotes revealed that homozygous mutants did not survive
Figure 1
Characterization and targeted disruption of the Cul1 locus. 
(a) Structure of the mouse Cul1 locus, targeting vector and the
disrupted mutant allele following homologous recombination. A
3′ flanking probe (A), a 5′ internal probe (B), and PCR primers (a–d)
were used to distinguish mutant from wild-type alleles. The targeting
vector removes 3 kb of genomic sequence that encodes a region
including the initiation codon (ATG) and the Skp1-binding site
(asterisk) in exon 2 (E2). (b) DNA from ES cell clones was amplified by
PCR using primers c and d, which yielded a fragment of 3.2 kb
corresponding to the mutant allele. (c) Absence of truncated Cul1
protein products in Cul1+/– ES cells. The indicated lysates were
immunoblotted with an anti-CUL1 antibody directed against the
carboxyl terminus of human CUL1. (d) Germline transmission of the
disrupted Cul1 allele. Tail DNA from a representative litter of a Cul1+/–
intercross was digested with SpeI and hybridized with the 3′ flanking
probe (probe A). The 4 and 5 kb fragments are derived from the mutant
and wild-type alleles, respectively. (e) Genotype analysis of E6.5
embryos from a representative Cul1+/– intercross. DNA was amplified
with primers a, b and d, and yields a 0.9 kb wild-type Cul1 product and
1.3 kb mutant Cul1 product. The Cul1 mutant allele segregated with
the expected Mendelian ratio (see the Supplementary material).
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beyond E7.5 (Figure 1e; see the Supplementary material).
Although Cul1–/– embryos were comparable in size to
wild-type embryos at E6.5, the mutant embryos stopped
developing at this point and were much smaller than wild-
type or heterozygous littermates by E7.5 (Figure 2a). His-
tological examination showed that mutant embryos
arrested before gastrulation with near normal morphology,
except that the embryonic ectoderm was thin with many
condensed nuclei (Figure 2b). The developmental arrest
of Cul1–/– embryos was accompanied by only a modest
increase in the number of apoptotic cells (Figure 2c). As
Cul1 is essential for early embryonic development, it is not
redundant with any of the nine other mammalian cullin
homologs that can be identified in current sequence data-
bases (A. Willems, personal communication).
To identify targets of Cul1-based SCF complexes, we
examined candidate substrates by immunohistochemical
staining of embryos. In wild-type and heterozygous
embryos, cyclin E was detected in a fraction of cells
(Figure 3a), consistent with its G1–S-specific cell-cycle
expression [7]. In marked contrast, intense cyclin E stain-
ing was detected in virtually every cell of Cul1–/–
embryos (Figure 3a). Importantly, cyclin E mRNA expres-
sion was not altered in Cul1–/– embryos (Figure 3b), indi-
cating that cyclin E did not accumulate as a result of
deregulated transcription.
We examined directly the role of Cul1 in cell proliferation
by following the development in vitro of E2.5 or E3.5
embryos derived from Cul1+/– intercrosses. Regardless of
genotype, most embryos hatched and formed blastocyst
outgrowths. After 4 days in culture, all outgrowths had an
expanded inner cell mass (ICM), some endodermal out-
growth and trophoblast giant cells (Figure 4a–d). In con-
trast to wild-type (n = 12) and heterozygous cultures
(n = 23), cells within Cul1–/– outgrowths (n = 10) failed to
proliferate beyond 7 days in culture. Attempts to derive
either Cul1–/– ES or trophoblast stem cell lines were
unsuccessful, consistent with an essential role for Cul1 in
proliferation of early embryonic cell types. Cyclin E
expression in wild-type blastocyst outgrowths was hetero-
geneous, and easily detectable in approximately one third
of trophoblast cells (Figure 4e), as expected for an asyn-
chronous population of cells in which cyclin E normally
oscillates during the endocycle [8]. In contrast, outgrowths
of Cul1–/– blastocysts contained abnormally large tro-
phoblast giant cells that had uniformly strong cyclin E
immunoreactivity (Figure 4f). 
To determine whether Cul1–/– trophoblast giant cells
undergo repeated endocycles despite the elevated cyclin
E levels, blastocyst outgrowths were pulse-labeled with
bromodeoxyuridine (BrdU). Both Cul1+/– and Cul1–/– out-
growths had a similar pattern of BrdU incorporation in
which only a fraction of trophoblast giant cells were
BrdU-positive, indicating that repeated rounds of DNA
replication still occurred in Cul1–/– trophoblast giant cells
(Figure 4g–j). Relative fluorescence intensity of nuclei
after DNA staining with bisbenzimide was used to esti-
mate ploidy levels. Compared to nuclei of parietal endo-
derm cells, trophoblast giant cells in wild-type and mutant
outgrowths had DNA contents that were on average
10-fold and 18-fold higher with average nuclear diameters
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Figure 2
Comparison of wild-type and Cul1 mutant
embryos. (a) Whole mounts of embryos of the
indicated genotypes at E6.5 and E7.5.
(b) Sagittal sections of wild-type and Cul1–/–
embryos at E6.5 were stained with
hematoxylin and eosin. (c) Loss of Cul1 does
not initiate widespread apoptosis. Nuclei with
detectable free DNA termini (arrowheads)
were visualized in E6.5 embryos by terminal-
deoxynucleotidyl-mediated dUTP nick-end
labeling (TUNEL) staining. EPC, ectoplacental
cone; EXE, extraembryonic ectoderm; EE,
embryonic ectoderm; VE, visceral endoderm.+/–
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of 32 µm (n = 776) and 51 µm (n = 61), respectively. These
data indicate that Cul1–/– trophoblast giant cells may actu-
ally undergo additional rounds of re-replication.
The reason for the developmental arrest of Cul1–/–
embryos is unknown. As cells can tolerate high levels of
cyclin E expression [7,9], it seems unlikely that accumula-
tion of cyclin E should cause arrest at E6.5. In view of the
emerging roles of SCF complexes in many cellular path-
ways, numerous substrates are likely to accumulate in
Cul1–/– embryos, one or more of which may account for
the developmental arrest. Known substrates of SCF com-
plexes in mammals include the signaling protein IκBα and
the transcription factor β-catenin, which are targeted by
the F-box protein β-TrCP [5]; and the transcription factor
E2F-1 and the cyclin-dependent kinase (Cdk) inhibitor
p27Kip1, which are targeted by the F-box protein SKP2 [6].
Although E2F-1 contributes to cyclin E expression [6],
E2F-1 is not expressed in early embryogenesis [10],
perhaps explaining why we did not observe accumulation
of cyclin E mRNA in Cul1–/– embryos. 
As in mice, cul-1 mutants in the nematode Caenorhabditis
elegans fail to undergo embryogenesis, provided that
maternal mRNA supplies are depleted [11]. Unlike the
mouse, maternal contributions of cul-1 suffice for com-
plete development of cul-1 mutants into sterile adults
which exhibit the remarkable propensity to undergo extra
rounds of cell division in all tissues [11]. The idea that the
additional divisions in cul-1 mutant nematodes might be
due to inappropriate G1 cyclin activity is consistent with
the accumulation of cyclin E in Cul1–/– cells in mice.
Although ectopic expression of cyclin E causes premature
S phase in Drosophila, continuous overexpression of cyclin
E in the fly salivary gland blocks the normal endoredupli-
cation cycle, suggesting that periodic cyclin E activity is
required to trigger the repeated rounds of DNA replica-
tion [12–14]. In mice, however, the accumulation of cyclin
E in Cul1–/– trophoblast giant cells did not appear to inter-
fere with the endocycle. Intriguingly, mice that lack Cul3,
another cullin gene family member, also arrest early in
development with elevated levels of cyclin E in some cell
types, including trophoblast cells [15]. Nevertheless, in
contrast to Cul1–/– mutants, Cul3–/– trophoblasts fail to
endocycle [15]. Thus, additional mechanisms may allow
periodic activation of cyclin E–Cdk2 in Cul1–/– cells but
not in Cul3–/– cells.
The most parsimonious explanation for the accumulation
of cyclin E protein in Cul1–/– cells is that Cul1 mediates
cyclin E degradation, although it is conceivable that the
effects of Cul1 on cyclin E are indirect. Proof that a Cul1-
based complex is the ubiquitin ligase for cyclin E awaits
direct demonstration that cyclin E is stabilized in Cul1–/–
cells, identification of the putative F-box protein for
cyclin E and reconstitution of ubiquitination activity
towards cyclin E in vitro. Elimination of the yeast G1
cyclin Cln2 and mammalian cyclin E by the ubiquitin
system proceeds through Cdk-dependent and -indepen-
dent pathways [16–18]. As Cul3 appears to target Cdk2-
free forms of cyclin E [15], Cul1-based complexes may
account for the degradation of Cdk2-bound, and hence
presumably phosphorylated, cyclin E. Consistent with
this possibility, Cul1–cyclin E complexes can be
detected only in the presence of active Cdk2 in heterolo-
gous expression systems (data not shown). As cyclin E is
a crucial rate-limiting activator of DNA replication and
centrosome duplication [7,19,20], both Cul1- and
Cul3-dependent degradation pathways may be necessary
to appropriately restrain its activity. Indeed, cyclin E is
abnormally regulated in many cancer cells [21] and recent
evidence suggests that excessive cyclin E activity leads
to chromosome instability [9]. 
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Figure 3
Cyclin E protein is elevated in Cul1–/– embryos in the absence of
altered levels of cyclin E mRNA. (a) Sagittal sections of Cul1+/– and
Cul1–/– embryos at E6.5 stained with anti-cyclin E antibody (see the
Supplementary material). Arrows indicate several representative
trophoblast giant cells. The original magnification was 100×. (b) In situ
hybridization of sagittal sections of Cul1+/– and Cul1–/– embryos at
E6.5 with an anti-sense cyclin E probe, visualized by dark field
microscopy. The original magnification was 200×.
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Supplementary material
A table showing genotypic and phenotypic analysis of Cul1+/– inter-
crosses, a figure showing Cul1 tissue distribution and cyclin E antibody
specificity, and further methodological detail are available at
http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Growth and development of blastocysts in
vitro. (a–d) Cul1–/– blastocysts cease growth
but still undergo differentiation. PE, parietal
endoderm; VE, visceral endoderm; TG,
trophoblast giant cells. (e,f) Cyclin E is
elevated in Cul1–/– blastocyst outgrowths.
After 11 days in culture, approximately one-
third of identifiable trophoblast cells in
Cul1+/+ and Cul1+/– outgrowths were
positive for cyclin E, whereas all TG cells in
Cul1–/– outgrowths contained detectable
cyclin E. Representative trophoblasts scored
as positive (black arrowheads) or negative
(white) for cyclin E are shown. (g–j) Cul1–/–
TG cells remain in the endocycle. Outgrowths
were labeled with BrdU after 11 days in
culture, and stained by anti-BrdU antibody
and bisbenzimide. Green arrowheads, BrdU+
cells; white, BrdU– cells.
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Supplementary materials and methods 
Targeted disruption of Cul1 in mice
Three overlapping phage clones from a 129/Sv mouse genomic library
were isolated using a 0.8 kb EcoRI fragment of the 5′ human CUL1
cDNA [S1]. A full-length mouse Cul1 cDNA is represented in the
expressed sequence tag (EST) databases (accession numbers
AA014775, AA549095, AI527547, AF083216) and is predicted to
encode a protein that is 96% identical to human CUL1. The structure
of approximately 30 kb of the mouse Cul1 gene was characterized by
restriction-enzyme mapping and sequencing. The initiation codon was
identified in exon 2, which was about 30 kb downstream of exon 1. A
3.1 kb StuI–SmaI genomic fragment upstream of exon 2 and a 1.5 kb
EcoRI fragment downstream of exon 2 were cloned into pPNT to
create a targeting vector, which was designed to avoid a LINE element
that is approximately 4 kb proximal to exon 2 (Figure 1a). Mouse R1 ES
cells were electroporated and selected using standard procedures
[S2]. Homologous recombinants were identified by PCR using primers
specific for sequences in the Cul1 gene and the neo cassette (upper
primer c, 5′-GGCTGGAGGAGGAATTGAGATGAACACAC-3′; lower
primer d, 5′-CAACGCTATGTCCTGATAGCGGTCC-3′) and con-
firmed by Southern blotting using a 3′ flanking probe (probe A) and an
internal probe (probe B; Figure 1a). Chimeric mice were generated by
aggregation of three correct ES cell clones with CD-1 morulae [S3],
one of which yielded germline transmission. Heterozygotes that gave
germline transmission of the targeted allele were bred into both 129/Sv
and 129/Sv × CD1 backgrounds. In every experiment involving
embryos, blastocysts and tissue sections, the status of the Cul1 locus
was determined by PCR using a three-primer combination (Figure 1a):
upper primer a, 5′-CAGAGGCCATGTCAGGAAAGTAA-3′; lower
primer b, 5′-ACTTTGCCATGCTTTGTCT-3′; lower primer d (see
above). PCR products were visualized by hybridization with internal
probes specific for wild-type and mutant alleles.
Phenotypic analysis
Deciduae were collected from uteri of plugged females at E5.5, E6.5,
E7.5 and E9.5. Samples were fixed for 4–12 h in 4% paraformalde-
hyde at 4oC, dehydrated, and embedded in paraffin. Sections 7 µm
thick were cut by microtome and processed for hematoxylin and eosin
staining and for immunohistochemical analysis. Embryo sections and
blastocyst outgrowths were stained by standard methods with an anti-
cyclin E antibody (M20, Santa Cruz; [S4–S6]) at 1:100 dilution and
Supplementary material
Figure S1
(a) Ubiquitous expression of Cul1 protein in different tissues. Total cell
lysates from adult mouse tissues, and insect-cell-expressed (bv) human
CUL1, were immunoblotted with a human anti-CUL1 antibody [S8]
and, as a loading control, with anti-α-tubulin antibody. (b) Specificity of
the anti-cyclin E antibody. Total cell lysates were separated on a 10%
gel by SDS–PAGE and blotted with anti-cyclin E antibody (M20, Santa
Cruz). Lane 1, Cul1+/– ES cells; lane 2, Cul1+/+ ES cells; lane 3,
human K562 cells. Note that the antibody does not cross-react with
human cyclin E.
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Table S1
Genotypic and phenotypic analysis of Cul1+/– intercross progeny.
Total Cul1+/+ Cul1+/– Cul1–/– Abnormal† Unknown‡
E6.5 14(30)* 4(6) 5(16) 3(8) 0(8) 2
E7.5 32 8 13 10 10 1
E9.5 12 4 5 0 0 3
Newborn 54 20 34 0 0 –
Neonates and embryos were genotyped by PCR and confirmed by
Southern analysis as described in the Supplementary materials and
methods. *Numbers in parentheses were derived from genotypes of
E6.5 embryonic sections. †Abnormal phenotypes in whole-mount assay
were characterized by reduced size and poor embryonic organization,
and, in the case of embryonic sections, abnormal phenotypes were
defined by the abundance of cyclin E staining and the presence of an
increased number of apoptotic cells. ‡Empty deciduae.
detected with a DAB substrate kit (Vector Laboratories). For in situ
hybridization, embryos were isolated in diethylpyrocarbonate (DEPC)-
treated PBS at E6.5 and processed as for immunohistochemical analy-
sis. Hybridization was performed using [α-33P]UTP-labeled cyclin E
anti-sense and sense probes. Apoptotic nuclei were detected with a
TUNEL assay kit (Boehringer Mannheim).
For blastocyst outgrowth experiments, superovulated females were
mated and morulae collected at E2.5 or E3.5. After cultivation in
KSOM medium for 48 h, blastocysts were individually cultured in 10 µl
drops of ES cell media without leukemia inhibitory factor overlayed with
paraffin oil in 5% CO2 at 37°C. For BrdU staining, outgrowths were
labeled with 10 µM BrdU for 1 h after 11 days in culture. After fixation
with 4% paraformaldehyde, outgrowths were treated with 2 M HCl, fol-
lowed by staining with anti-BrdU antibody (Zymed). At the end of most
outgrowth experiments, blastocysts were genotyped by PCR in combi-
nation with Southern blot analysis.
Immunoblot analysis
Cell lysates were prepared in 50 mM Tris at pH 7.5, 150 mM NaCl,
5 mM NaF, 5 mM EDTA, 0.1% NP-40, 10% glycerol, 15 mM β-glyc-
erolphosphate, 1 mM PMSF, 1 µg/ml leupeptin, 1 µg/ml pepstatin,
10 µg/ml TPCK and 10 µg/ml soybean trypsin inhibitor. Lysates were
centrifuged at 10,000 × g for 15 min twice at 4°C. Immunoblots were
performed as described previously [S7]. Anti-Cyclin E (M20, Santa
Cruz) and anti α-tubulin antibodies (MAS 078, Harlan SERA-LAB)
were used at 1:3000 and 1:1000, respectively. An antibody directed
against a conserved carboxy-terminal peptide in the human CUL1
sequences was used as described previously [S8]. Specificity of CUL1
immunoreactivity was confirmed with two other independent anti-CUL1
antisera (data not shown).
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